Detalles de la búsqueda
1.
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 194: 106859, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37473877
2.
Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis.
Int J Mol Sci
; 24(19)2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833895
3.
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675312
4.
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis.
Pharmacol Res
; 152: 104594, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838077
5.
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
; 71(4): 508-515, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32773718
6.
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Int J Mol Sci
; 21(9)2020 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32397546
7.
Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease.
Int J Mol Sci
; 21(2)2020 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31968593
8.
Genetic predictors of long-term response and trough levels of infliximab in crohn's disease.
Pharmacol Res
; 149: 104478, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605784
9.
Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits.
Clin Chem Lab Med
; 57(12): 1906-1914, 2019 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085742
10.
Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
Pharmacol Res
; 136: 133-139, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30213564
11.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 196: 106938, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748560
12.
Identification of new SNPs associated with severe toxicity to capecitabine.
Pharmacol Res
; 120: 133-137, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28347776
13.
Withdrawal: A novel germ line-specific gene of the phosducin-like protein (PhLP) family: A meiotic function conserved from yeast to mice.
J Biol Chem
; 294(37): 13832, 2019 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31519761
14.
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.
Pharmacogenet Genomics
; 24(5): 231-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24595012
15.
Comments on: "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan".
Pharmacol Res
; 145: 104288, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31141714
16.
The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.
Paediatr Drugs
; 26(3): 331-346, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38507036
17.
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Biomed Pharmacother
; 173: 116299, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401525
18.
A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.
BMC Genomics
; 14: 55, 2013 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23350875
19.
Carbosilane dendrimer 2G-NN16 represses Tc17 differentiation in primary T CD8+ lymphocytes.
Mol Pharm
; 9(1): 102-10, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22023154
20.
Pharmacogenetics to Avoid Adverse Drug Reactions.
J Pers Med
; 12(2)2022 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35207648